These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26563477)

  • 41. Localization of CHMP2B-immunoreactivity in the brainstem of Lewy body disease.
    Kurashige T; Takahashi T; Yamazaki Y; Hiji M; Izumi Y; Yamawaki T; Matsumoto M
    Neuropathology; 2013 Jun; 33(3):237-45. PubMed ID: 22989140
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
    Iwatsubo T
    Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alpha-synuclein immunoreactivity is present in axonal swellings in neuroaxonal dystrophy and acute traumatic brain injury.
    Newell KL; Boyer P; Gomez-Tortosa E; Hobbs W; Hedley-Whyte ET; Vonsattel JP; Hyman BT
    J Neuropathol Exp Neurol; 1999 Dec; 58(12):1263-8. PubMed ID: 10604751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phosphorylated α-synuclein immunoreactivity in the posterior pituitary lobe.
    Homma T; Mochizuki Y; Mizutani T
    Neuropathology; 2012 Aug; 32(4):385-9. PubMed ID: 22082318
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of topographical distribution of α-synuclein pathology on TDP-43 accumulation in Lewy body disease.
    Yokota O; Davidson Y; Arai T; Hasegawa M; Akiyama H; Ishizu H; Terada S; Sikkink S; Pickering-Brown S; Mann DM
    Acta Neuropathol; 2010 Dec; 120(6):789-801. PubMed ID: 20669025
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease.
    Anderson JP; Walker DE; Goldstein JM; de Laat R; Banducci K; Caccavello RJ; Barbour R; Huang J; Kling K; Lee M; Diep L; Keim PS; Shen X; Chataway T; Schlossmacher MG; Seubert P; Schenk D; Sinha S; Gai WP; Chilcote TJ
    J Biol Chem; 2006 Oct; 281(40):29739-52. PubMed ID: 16847063
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selective expression of α-synuclein-immunoreactivity in vesicular acetylcholine transporter-immunoreactive axons in the guinea pig rectum and human colon.
    Sharrad DF; de Vries E; Brookes SJ
    J Comp Neurol; 2013 Feb; 521(3):657-76. PubMed ID: 22821666
    [TBL] [Abstract][Full Text] [Related]  

  • 48. α-Synucleinopathy phenotypes.
    McCann H; Stevens CH; Cartwright H; Halliday GM
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S62-7. PubMed ID: 24262191
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein.
    Bernis ME; Babila JT; Breid S; Wüsten KA; Wüllner U; Tamgüney G
    Acta Neuropathol Commun; 2015 Nov; 3():75. PubMed ID: 26612754
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glial involvement in diffuse Lewy body disease.
    Terada S; Ishizu H; Yokota O; Tsuchiya K; Nakashima H; Ishihara T; Fujita D; Uéda K; Ikeda K; Kuroda S
    Acta Neuropathol; 2003 Feb; 105(2):163-9. PubMed ID: 12536227
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuropathology underlying clinical variability in patients with synucleinopathies.
    Halliday GM; Holton JL; Revesz T; Dickson DW
    Acta Neuropathol; 2011 Aug; 122(2):187-204. PubMed ID: 21720849
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dopamine cell loss in the periaqueductal gray in multiple system atrophy and Lewy body dementia.
    Benarroch EE; Schmeichel AM; Dugger BN; Sandroni P; Parisi JE; Low PA
    Neurology; 2009 Jul; 73(2):106-12. PubMed ID: 19597132
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.
    Higashi S; Iseki E; Yamamoto R; Minegishi M; Hino H; Fujisawa K; Togo T; Katsuse O; Uchikado H; Furukawa Y; Kosaka K; Arai H
    Brain Res; 2007 Dec; 1184():284-94. PubMed ID: 17963732
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Over-expression of alpha-synuclein in the nervous system enhances axonal degeneration after peripheral nerve lesion in a transgenic mouse strain.
    Siebert H; Kahle PJ; Kramer ML; Isik T; Schlüter OM; Schulz-Schaeffer WJ; Brück W
    J Neurochem; 2010 Aug; 114(4):1007-18. PubMed ID: 20524960
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Localization of nuclear receptor subfamily 4, group A, member 3 (NR4A3) in Lewy body disease and multiple system atrophy.
    Kon T; Miki Y; Tanji K; Mori F; Tomiyama M; Toyoshima Y; Kakita A; Takahashi H; Utsumi J; Sasaki H; Wakabayashi K
    Neuropathology; 2015 Dec; 35(6):503-9. PubMed ID: 26096603
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies.
    Klucken J; Ingelsson M; Shin Y; Irizarry MC; Hedley-Whyte ET; Frosch M; Growdon J; McLean P; Hyman BT
    Acta Neuropathol; 2006 Feb; 111(2):101-8. PubMed ID: 16482476
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease.
    Braak H; Sastre M; Del Tredici K
    Acta Neuropathol; 2007 Sep; 114(3):231-41. PubMed ID: 17576580
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuroimaging for Lewy body disease: is the in vivo molecular imaging of α-synuclein neuropathology required and feasible?
    Vernon AC; Ballard C; Modo M
    Brain Res Rev; 2010 Oct; 65(1):28-55. PubMed ID: 20685363
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tuft-shaped astrocytes in Lewy body disease.
    Hishikawa N; Hashizume Y; Yoshida M; Niwa J; Tanaka F; Sobue G
    Acta Neuropathol; 2005 Apr; 109(4):373-80. PubMed ID: 15668789
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 14-3-3 protein sigma isoform co-localizes with phosphorylated α-synuclein in Lewy bodies and Lewy neurites in patients with Lewy body disease.
    Wakabayashi K; Umahara T; Hirokawa K; Hanyu H; Uchihara T
    Neurosci Lett; 2018 May; 674():171-175. PubMed ID: 29555518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.